openPR Logo
Press release

Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Osivax, CureVac AG

08-26-2024 11:12 PM CET | Health & Medicine

Press release from: ABNewswire

Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics,

DelveInsight's, "Influenza Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in Influenza pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Discover the latest drugs and treatment options in the Influenza Pipeline. Dive into DelveInsight's comprehensive report today! @ Influenza Pipeline Outlook [https://www.delveinsight.com/sample-request/influenza-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Key Takeaways from the Influenza Pipeline Report

* August 2024:- Hoffmann-La Roche- A Phase IIIb Multicenter, Single-Arm, Open-Label Surveillance Study of Susceptibility to Baloxavir Marboxil in Patients With Influenza. The purpose of this study is to evaluate the pre-treatment and single-dose post treatment susceptibility of baloxavir marboxil in participants aged 1 to
* August 2024:- Janssen Vaccines & Prevention B.V.- A Randomized, Double-blind, Placebo-controlled, First-in-human Phase 1/2a Study to Evaluate Safety, Reactogenicity and Immunogenicity of a Universal Influenza (Uniflu) Vaccine With INFLUENZA G1 mHA in Healthy Adults. The primary purpose of this study is to evaluate safety/ reactogenicity of INFLUENZA G1 mini-hemagglutinin stem-derived protein vaccine antigen (mHA), with or without Al(OH)3 adjuvant, in healthy adults greater than or equal to (>=) 18 to less than or equal to (



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Osivax, CureVac AG here

News-ID: 3635365 • Views:

More Releases from ABNewswire

IBN Technologies vCISO Service Become U.S. Firms Strategic Choice for Cyber Defense
IBN Technologies vCISO Service Become U.S. Firms Strategic Choice for Cyber Defe …
IBN Technologies' managed vCISO services give U.S. businesses access to certified security leaders without the high cost of full-time hires. Offering compliance expertise, risk management, and tailored cybersecurity strategies, the service ensures rapid deployment, regulatory alignment, and proactive defense. Scalable models deliver enterprise-class protection for firms of all sizes. The need for competent cybersecurity leadership is growing faster than the talent pool due to the ongoing increase in cyberattacks worldwide. Many
IBN Technologies Expands BCDR Services to Help Firms Combat Cyber Threats
IBN Technologies Expands BCDR Services to Help Firms Combat Cyber Threats
IBN Technologies strengthens its Business Continuity and Disaster Recovery (BC/DR) services to help organizations combat rising cyber threats, natural disasters, and system outages. With DRaaS, continuous backups, ransomware protection, and global data residency options, IBN enables firms to reduce downtime, safeguard assets, and maintain business resilience in a digital-first economy. To protect operations and minimize financial losses, businesses all over the world are increasing their investments in Business Continuity and Disaster
IBN Technologies Expands Civil Engineering Outsourcing to Enhance Global Project Outcomes
IBN Technologies Expands Civil Engineering Outsourcing to Enhance Global Project …
Civil engineering outsourcing is reshaping how organizations manage complex construction and infrastructure projects. Companies are leveraging external expertise to streamline workflows, maintain compliance with global standards, reduce costs, and ensure accurate project delivery. The report covers practical strategies, technological tools, and operational frameworks driving measurable outcomes in civil engineering. Miami, Florida - 09 Oct, 2025 - The construction and infrastructure sector is under mounting pressure as urban development, residential expansion, and
Civil Engineering Outsourcing by IBN Technologies Gains Momentum as Businesses Seek Smarter Project Delivery
Civil Engineering Outsourcing by IBN Technologies Gains Momentum as Businesses S …
The news highlights how civil engineering outsourcing is helping organizations manage complex infrastructure and residential projects while reducing costs and maintaining compliance with global standards. It outlines the industry challenges, the role of expert outsourcing partners, and how advanced tools and proven methodologies support project accuracy, efficiency, and dependable delivery for businesses. As urban expansion and infrastructure development accelerate, construction firms and property developers are encountering growing demands for precision, speed,

All 5 Releases


More Releases for Influenza

Multivalent Influenza Vaccines Market Advancing Influenza Prevention Strategies …
The "Multivalent Influenza Vaccines Market" research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Multivalent Influenza Vaccines industry along with various other factors over the predicted period 2024-2030. The report on the Multivalent Influenza Vaccines market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels, profit margin, etc.
Influenza Diagnostics Market - Rapid Detection, Effective Protection: Influenza …
Newark, New Castle, USA: The "Influenza Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Influenza Diagnostics Market: https://www.growthplusreports.com/report/influenza-diagnostics-market/8780 This latest report researches the industry structure, sales, revenue,
Influenza Medication Market - Fight off the influenza virus with effective and r …
Newark, New Castle, USA: The "Influenza Medication Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Influenza Medication Market: https://www.growthplusreports.com/report/influenza-medication-market/7859 This latest report researches the industry structure, sales, revenue,
Influenza Medication Market - Revolutionizing Flu Treatment: Innovating Advanced …
Newark, New Castle, USA - new report, titled Influenza Medication Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Medication market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Medication market. The report offers an overview of the market, which
Influenza Vaccines Market - Empowering Strength, Nurturing Immunity: Innovating …
Newark, New Castle, USA - new report, titled Influenza Vaccines Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Vaccines market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Vaccines market. The report offers an overview of the market, which
H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,